Signaturefd, LLC Red Hill Biopharma Ltd. Transaction History

Signaturefd, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$2.31 - $5.85 $672 - $1,702	-291 Reduced 74.42%	100 $0
Q3 2021 Oct 28, 2021	SELL	$4.55 - $10.36 $1,392 - $3,170	-306 Reduced 43.9%	391 $2,000
Q2 2021 Jul 26, 2021	SELL	$5.98 - $7.51 $759 - $953	-127 Reduced 15.41%	697 $5,000
Q1 2021 Apr 30, 2021	BUY	$6.98 - $11.29 $3,413 - $5,520	489 Added 145.97%	824 $6,000
Q4 2020 Feb 11, 2021	BUY	$7.81 - $10.39 $1,476 - $1,963	189 Added 129.45%	335 $3,000
Q3 2020 Nov 03, 2020	BUY	$6.34 - $10.83 $925 - $1,581	146 New	146 $1,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.